This Analyst Believes Precigen's Non-Healthcare Divesture Removes Financial Overhang

Yesterday, Precigen Inc  (NASDAQ: PGEN ) agreed to sell its non-healthcare subsidiary to URUS. HC Wainwright  says they are encouraged by the divestiture of the company's non-core business and believe management deserves much credit, especially against the backdrop of the challenging macro environment.  Related:   Why Precigen Shares Are Gaining Today ? The analyst believes the completed transaction would remove the financial overhang related to the approximate $200 million convertible notes that mature in July 2023.  The company ... Full story available on